Skip to main content


Latest articles

30-03-2020 | Oncology | News | Article

UK-based cancer and coronavirus registry initiated

Oncologists from the UK have jointly launched the UK Coronavirus Cancer Monitoring Project to collate data on cancer patients who acquire COVID-19.

27-03-2020 | Oncology | News | Article

COVID-19 cancer registry launched in USA

The COVID-19 and Cancer Consortium – CCC19 – which aims to collect data on cancer patients with SARS-CoV-2 infection has launched.

27-03-2020 | Oncology | News | Article

Osimertinib risk for cardiac adverse events highlighted

Around 5% of non-small-cell lung cancer patients using osimertinib monotherapy may experience severe cardiac adverse events, suggests a study of Japanese patients.

25-03-2020 | Oncology | News | Article

Cancer linked to increased COVID-19 risk

The risk for acquiring SARS-CoV2 infection appears to be more than twofold higher for people with cancer than the general community, indicates a chart review.

25-03-2020 | Oncology | Highlight | Article

Carboplatin–pemetrexed should be ‘a standard option’ for older NSCLC patients

Carboplatin–pemetrexed plus pemetrexed maintenance is noninferior to docetaxel for the first-line treatment of advanced non-small-cell lung cancer in patients aged 75 years or older, suggests a phase 3 Japanese study.

24-03-2020 | Oncology | News | Article

ESMO updates cancer-related fatigue recommendations

Read more on this here

Image Credits